Propofol for sedation and control of intracranial pressure in children

Area of Science:

• Neuroscience
• Critical Care Medicine
• Pediatric Neurology

Background:

• Elevated intracranial pressure (ICP) following central nervous system insults is a significant factor contributing to morbidity and mortality.
• Current ICP management strategies include osmolar agents, seizure control, cerebrospinal fluid drainage, hypothermia, and barbiturates.
• Sedation and control of patient agitation are vital components in managing ICP, with opioids and benzodiazepines as common choices.

Observation:

• This study presents two pediatric cases where propofol was utilized to manage increased ICP.
• Propofol was administered to provide sedation and facilitate ICP control in these children.
• The use of propofol was considered when conventional methods were potentially insufficient or as an alternative approach.

Findings:

• Propofol demonstrated efficacy in providing sedation for pediatric patients experiencing elevated ICP.
• The use of propofol contributed to the management and control of intracranial pressure in the presented cases.
• This suggests propofol as a viable option for specific pediatric scenarios involving increased ICP.

Implications:

• Propofol may serve as an effective alternative or adjunctive agent for sedation in pediatric patients with elevated ICP.
• Further investigation into propofol's role in managing intracranial pressure is warranted.
• These findings could inform clinical practice guidelines for pediatric neurocritical care.